IP Verse

Mikrogen competitive analysis

Latest oppositions filed by Mikrogen

Explore patent oppositions filed by Mikrogen against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
EP3869199
A Method And Reagents For The Diagnosis Of Sars-Cov-2CHARIT UNIVERSITTSMEDIZIN BERLINOct 10, 2022
EP1589109
Vmp-Like Sequences Of Pathogenic BorreliaBOARD OF REGENTSJan 9, 2018

Latest patents of Mikrogen opposed by its competitors

Explore Mikrogen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2396655
Dec 6, 2017Device For Serologically Detecting Yersinia Infections And/Or Secondary Diseases Thereof And Use Of The Proteins Myfa And Psaa Of Y. Enterocolitica And Y. Pseudotuberculosis As Recombinant Antigens1

Latest PTAB cases involving Mikrogen

Discover the latest PTAB cases involving Mikrogen, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Mikrogen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MIKROGEN21 - -
BOARD OF REGENTS - 8 - 5
CHARIT UNIVERSITTSMEDIZIN BERLIN - 4 - -
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA104 - -